1. The Grant Writing and Review Process at NIH Joshua Smyth Professor of Biobehavioral Health and Medicine; Associate Director, SSRI Rhonda BeLue Associate Professor of Health Policy and Administration Jenae Neiderhiser Professor of Psychology Danielle Downs Associate Professor of Kinesiology and Obstetrics & Gynecology

2. Thanks to: Lori Francis, Associate Professor of Biobehavioral Health Brittany Frost, Social Science Research Institute

3. NIH Organization NIH Funding Mechanisms The Grant Writing Process Focus on the R01 The NIH Review Process Overview of Review Meeting The Scoring Process A Penn State example Workshop Evaluation Workshop Outline

4. I. The NIH  Department of Health and Human Services  National Institutes of Health  25 Awarding Institutes/Centers aka ICs  e.g., NICHD, NIMH, NIDA, NIA, etc.  Center for Scientific Review  Office of the Director

5. The NIH Extramural Team A. Program B. Grants Management C. Review

6. A. The Program/Institute Staff Program Administrator Maintains knowledge of scientific area Attends study section meetings Makes funding recommendations Monitors scientific progress Identifies scientific area of importance Reports to senior staff Development of programs and initiatives

7. B. Grants Management  Interprets Federal regulations and policies  Assures compliance with Federal regulations and policies  Monitors financial aspects of projects  Interprets regulations and policy

8. C. Review: Scientific Review Group (1 st Level)  Center for Scientific Review (CSR) or NIH Institute & Center (IC)  Scientific Review Group (SRG)  Non-federal scientists with relevant expertise  Led by a Scientific Review Officer (SRO)  http://www.csr.nih.gov/Roster_proto/sectionI.asp

9. C. Review: Advisory Council or Board (2 nd Level) The potential awarding IC performs the second level of review NIH program staff examine applications for impact (formerly “priority”) scores, percentile rankings, & summary statements against the IC’s needs Program staff provide grant funding plan to Advisory Council or Board Advisory Council or Board advises the IC director Director makes final decision

10. NIH Grant Application Cycle Allocates Funds Investigator NIHInstitution Submits Application Peer Review Council Review Funding Decision Initiates Research Conducts Research

11. Grant Application: It’s a process, not an event 1.Communicate with Program Officer  Introducing ideas, getting feedback, pre-review 2. Get your proposal to the right review committee  Review the rosters and talk to colleagues  Effectively wording the abstract  Make a written request 3. Seek feedback from colleagues and consultants on drafts of the grant (prepare ahead!) 4. Consider who is likely to review your grant (review the rosters) and make sure to know and cite their work when relevant 5. Recognize that funding on first submission is rare

12. Ks: NIH Career Development Awards (K01, K02, K05, K07, K08, K22 [K99/R00]) P01: Research Program Project Grant P30: Center Core Grants R01: NIH Research Project Grant Program R03: NIH Small Grant Program R13: NIH Support for Conferences and Scientific Meetings (R13, U13) R15: NIH Academic Research Enhancement Award (AREA) II. NIH Grant Mechanisms

13. R21: NIH Exploratory/Developmental Research Grant Award R34: NIH Clinical Trial Planning Grant T series: NRSA Training Grants (T32, T34, T35, T90, etc.) U series: Research Project Cooperative Agreement Diversity Supplements: Research Supplements to Promote Diversity in Health-related Research Roadmap: NIH Roadmap Initiatives (Director’s Pioneer Award; Director’s New Innovative Program) NIH Grant Mechanisms (continued)

14. R01 (primary focus today) Used to support a discrete, specified, circumscribed research project NIH’s most commonly used grant program Body of the grant (Research Strategy) is 12 pages (mostly single spaced) Generally awarded for 3 to 5 years Up to $500,000/year without exceptions needed Advance permission required for $500,000 or more (direct costs) in any year

15. New and Early Stage Investigators: A Competitive Edge New Investigator has not previously served as a PI for an R01; may have been an investigator or received other smaller, developmental or research training awards Early Stage Investigator (ESI) is within 10 years of completing her/his terminal research degree, or completing medical residency

16. Grant writing is: A skill like any other… But not the same skill as article writing Instead, more of a problem-based writing activity (theory and practice problem) III. The Grant Writing Process

17. Start early, make a timeline and STICK TO IT Should allow time for serious pre-submission review and subsequent revision Develop a relationship with project officers It is not possible to overdo clarity Let your passion come through in your proposal Take advantage of early stage and new investigator opportunities A few preliminary tips

18. Know what has been done Know what has been funded NIH website RePORTER (formerly CRISP) Decide on the problem Important enough to get funded but simple enough to explain as clean design in 12 pp for the R01; less for some other mechanisms Assemble team Complementary skills; Seniority/competence/other by association; People you can count on Getting ready to write

19. Communicate with program officer Establish a relationship and trust (funding decision) Acquire information on mechanism and priorities Obtain input on aims/proposal Getting ready to write

20. Face Page Table of Contents Performance Sites Other information Project Summary (Description) Public Health Relevance Statement Facilities & Resources Main Sections of the NIH Application (see Francis et al. for some examples)

21. Key Personnel Biosketches -- with personal statements Budgets (for each study year) Budget Justification Other sections (not discussed today); for example: Clinical Trial and Human Embryonic Stem Cell (HESC) List of Research Plan Attachments More Sections

22. [Introduction – revisions only] Specific Aims: The basis for the proposal’s organization Research Strategy Significance and Innovation Approach Preliminary studies Design Sample/recruitment/power analyses Procedures & measures Analyses Main Sections of the R01: Specific Research Plan

23. Page Limit Guide: Plan your proposal with these limits in mind Section of ApplicationPage Limits Introduction (for resubmission application only)1 Specific Aims1 Research Approach: R03, R13/U13, R21, R36, R41, R43, Fellowships (F), SC2, SC3 6 Research Approach: R01, single project U01, R10, R15, R18, U18, R33, R24, R34, U34, R42, R44, DP3, G08, G11, G13, UH2, UH3, SC1 12 Biographical Sketch4 Page limits may vary for other funding mechanisms. Check Funding Opportunity Announcement: http://grants.nih.gov/grants/guide/search_results.htm?scope=pa&year=active

24. Protection of Human Subjects Women and Minorities Planned Enrollment Table Children References Cited Letters of Support Resource Sharing Plan Checklist SO START EARLY! And More Sections

25. Clarity is key – each point follows naturally Tell a (scientific) story Everything that needs to be there, is; nothing extra Communicate your excitement Get feedback early on And often General themes of success

26. Impact and Significance Practice (2-3 sentences) Prevalence of problem in population Important social concern/public health problem Theory (model) Building, testing, using Innovation New directions, value added Compelling Preliminary Research General themes to R01 Success

27. Specific Aims may be only part read by some reviewers No more than one page Tell the entire story Functions as an abstract would in a manuscript End with (actual) specific aims Hypotheses and aims must align Keys to Success – Specific Aims

28. Background and significance Used to be an explicit section; no longer This is where you ‘hook’ the reader on your story Functions as the ‘introduction’ does in a manuscript Likely no more than 2-3 pages Keys to Success – Background

29. Research team collaboration no longer required to be documented Still very helpful Preliminary study ‘types’ – document: Relevant previous research Research that demonstrates competence in requisite domains Capacity to recruit in specific populations and/or contexts Pilot data specific to proposal Preliminary Studies

30. Methods are very important Overall -- clarity and detail May include a table that traces aims to hypotheses to constructs to measures (table/s) Is the design feasible? Are there gaps in the methods (e.g., fidelity for interventions) Statistics are essential – product must match aims Consider a methodologist team member Include a detailed timeline Keys to Success - Methods

31. Preference for representative samples Students only if relevant to age/situation (e.g., college drinking) Generalizability from a single entity (university, clinic, state) Justified exclusions Unit of assignment is unit of analysis Sample size/power analysis For each outcome/planned test And More Methods: The Sample

32. Direct Costs Senior Personnel (PI, co-Is, project director) (PSU fringe at 36.5%) Other Personnel (full time staff, RAs, part time wages) (PSU fringe 36.5% for full time staff, 13.2% for Grad Assts AY; 7.9% for part time wages and summer) Equipment Travel Participant/Trainee Support Costs Budgets

33. Other Materials and supplies Publication costs Consultant services Subawards/Consortium/Contractual Fees Other Indirect Costs (~50% at PSU, but does not include all expenses) Budget justification Budgets, cont.

34. Receiving the Summary Statements: The Hardest Part! 1.Reviews critical, even harsh 2.Reviewers usually find grant’s weaknesses, while recognizing strengths 3.Summary statements spend much more time on critique than praise 4.Many investigators experience a mixture of rage and depression when they read their summary statements and easily lose perspective 5.Take a day or two (or more!) and then read again with a cooler head

35. Receiving the Summary Statements: Bouncing Back! 1.Ask experienced colleagues to read reviews 2.Don’t interpret criticism as hopeless 3.Program Officer may be helpful in clarifying critique 4.If “discussed” (rather than triaged), you have a chance of funding in next round 5.The lower the initial score, the fewer problems and more likely to be successful after revision

36. 1.Persistence pays off in the grant process!! 2.Second submission must respond to the critiques through revision or clearly defending reasoning 3.Same reviewers may or may not review resubmission, but will see critique Resubmission: Resilience and Flexibility!

37. Most Common Reasons for a Poor Score (in priority order) Lack of impact or significance Lack of new or original ideas Hypotheses ill-defined, superficial, lacking, unfocused, or unsupported by preliminary data Methods unsuitable, not feasible, not rigorous or not likely to yield results; methods don’t clearly link to aims Design not logical, inappropriate instrumentation, poor timing or conditions; doesn’t link well to aims Data management and analysis vague, not rigorous; analyses don’t clearly link to aims Inadequate expertise or knowledge of field for PI; too little time to devote to the work Poor resources or facilities; limited access to appropriate population

38. When to Revise Basic idea was significant and innovative or these can be bolstered Design/measurement/analysis problems can be clarified (more information) or fixed Need preliminary data Problem is poor writing

39.  A. The Review Meeting  B. Review Discussion  C. The Scoring Process  D. A Penn State Example IV. The NIH Review Process

40. A. The Review Meeting: The SRO’s Role Prior to Meeting  Point of contact until review group meets (then project officer)  Analyze submissions for completeness and conflicts  Recruit ad hoc reviewers as needed  Schedule 1-2 day meeting  Assign applications to reviewers (at least 3)  Primary, secondary, discussant  Create review order based on preliminary impact scores from best to worst within categories

41. Reviewers’ Role Prior to Meeting  Familiarize self with criteria, mechanisms, and scoring  Review assigned applications  Assign scores to each criteria and other areas  Write bulleted strengths and weaknesses for each criteria  Reviews are advice to institutes for funding decisions, not advice to PI  Post scores and comments on NIH Commons  Read other reviews of assigned applications  Prepare presentation of reviews  Skim/read non-assigned applications

42. Format of the Review Meeting SRO opening remarks Chair orientation New investigator R01 grants Other R01 grants Other grant types (R03, R15, R21, R34) Applications discussed in order of Impact Score; bottom 50% are not discussed

43. Confidentiality Review order Proposals below median within each category may not be discussed SRO Opening Remarks

44. Chair Orientation  Start with reviewer impact scores  May differ from posted scores  Goal of discussion is to clarify not reach agreement  If scores are similar, shorter discussion  If scores are dissimilar, longer discussion  Recommended time  Primary – 5 minutes  Secondary – 3 minutes  Discussant – 2 minutes

45. B. Review Discussion Identify proposal Members in conflict leave Reviewers provide preliminary impact scores Reviews Impact, Significance, Investigators, Innovation, Approach, Environment Stress main points, do not repeat previous points Non-reviewers typically ask questions to clarify Human Subjects issues affecting scoring Open discussion to entire committee

46. Review Discussion (continued) Ask for reviewers impact scores again Identify the reviewers’ recommended range Ask if anyone wants to score outside the range Entire committee records impact score Discuss budget and other issues

47. C. The Scoring Process 1. Overall Impact Score: likelihood project will “exert a sustained, powerful influence on the research field(s) involved (1-9 scale) 2. A separate 1-9 score for each of 5 core criteria (Significance, Investigators, Innovation, Approach, Environment) 3. Additional review criteria help determine scientific and technical merit BUT are not scored separately 4. Additional review considerations are addressed by reviewers, but are not scored & are discussed after group scores

48. Score Criteria Overall Impact : will project exert a sustained, powerful influence on the research field(s) as indexed by 5 core review criteria 1. Significance: important problem addressed; how will this improve scientific knowledge, technical capability, and/or clinical practice

49. Impact Addresses: Probability of whether the research will exert a sustained, powerful influence on the research field Significance Addresses: Does the project address an important problem or a critical barrier to progress in the field? If the aims are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? What is the Difference Between Impact and Significance ?

50. Score Criteria (continued) 2. Investigators: PI & other researchers well suited to the project; appropriate experience & training; ongoing record of accomplishments; complementary & integrated experience; leadership approach, governance, and organizational structure appropriate for project 3. Innovation: the work challenges and seeks to shift current research or practice paradigms; utilizing novel theory, approaches or methods, instrumentation, or interventions; the work is novel (Be innovative, but maybe not too innovative…)

51. Score Criteria (continued) 4. Approach: strategy, methodology, analyses are well- reasoned and appropriate; potential problems & alternative strategies thought through; benchmarks set; risk is managed Most common reviewer complaint is lack of detail here Typically the longest section 5. Environment: the environment will contribute to the project’s success; institutional support, equipment, & other resources sufficient; unique features of the environment, subject population, collaborative arrangements

52. Additional Review Criteria ( not scored) Human Subjects: 1. Protection of human subjects 2. Data safety monitoring plan (clinical trials only) 3. Inclusion of women, minorities, children 4. Vertebrate animals 5. Biohazards

53. Additional Review Considerations 1. Budget and period of support 2. Select agent research (infectious agents) 3. Applications from foreign organizations 4. Resource sharing plans

54. CRITERIA SCORING SYSTEM HIGH 1. Exceptional: Exceptionally strong with essentially no weaknesses 2. Outstanding: Extremely strong with negligible weaknesses 3. Excellent: Very strong with only some minor weaknesses MEDIUM 4. Very Good: Strong but with numerous minor weaknesses 5. Good: Strong but with at least one moderate weakness 6. Satisfactory: Some strengths but also some moderate weaknesses Low 7. Fair: Some strengths but with at least one major weakness 8. Marginal: A few strengths and a few major weaknesses 9. Poor: Very few strengths and numerous major weaknesses

55. CRITERIA SCORING SYSTEM (continued) Minor Weakness: An easily addressable weakness that does not substantially lessen impact Moderate Weakness: A weakness that lessens impact Major Weakness: A weakness that severely limits impact

56. CRITERIA SCORING SYSTEM (continued) Final Overall Impact Score: Mean of all reviewers’ final impact scores X 10 Range = 10 (high impact) -- 90 (low impact) NOTE: Scoring likely to produce applications with identical scores (“ties”). Thus, other factors (e.g., mission relevance, portfolio balance) will be considered when all other things are essentially equal

57. Research Plan Components Specific Aims Research Strategy Includes Background & Significance; Preliminary Studies/Progress Report; Research Design & Methods Facilities and Equipment Reflects the Environment criterion For ESIs should describe the institutional investment in the success of the investigator Biographical Sketch [NEW! as of Jan 25 th, 2015 ] Personal statement – why well-suited for project, 4 pubs Contribution to science - you describe up to 5 of your most significant scientific contributions (<=1/2 page each); up to 4 pubs or other products for each contribution area Key Sections in R01 Proposal Format

58. D. A Penn State Example Mock NIH Study Section Chair: Joshua Smyth, Associate Director, SSRI Reviewer #1: Rhonda BeLue, Associate Professor of Health Policy and Administration Reviewer #2: Jenae Neiderhiser, Professor of Psychology Reviewer #3: Danielle Downs, Associate Professor of Kinesiology and Obstetrics & Gynecology Review group members: Workshop attendees

59. Enhancing Peer Review Criteria: http://grants.nih.gov/grants/guide/notice-files/not-od-09- 025.html http://grants.nih.gov/grants/guide/notice-files/not-od-09- 025.html Page Limits: http://grants.nih.gov/grants/forms_page_limits.htm Human Subjects: http://grants.nih.gov/grants/policy/hs/index.htm http://grants.nih.gov/grants/policy/hs/index.htm SF424 guidelines for submission: http://grants.nih.gov/grants/funding/424/index.htm http://grants.nih.gov/grants/funding/424/index.htm Glossary: http://grants.nih.gov/grants/glossary.htm Links of Interest

60. NIH RePorter (formerly CRISP) https://libraries.ucsd.edu/info/resources/nih-reporter- formerly-crisp Revised Applications http://grants.nih.gov/grants/policy/amendedapps.htm NIH Grant Writing Tip Sheets http://grants.nih.gov/grants/grant_tips.htm Getting an RO1 http://sciencecareers.sciencemag.org/career_development/ previous_issues/articles/1190/getting_an_nih_r01 General Resources

61. NSF Proposal Writing http://www.cs.cmu.edu/~sfinger/advice/advice.html Other Proposal Writing Guides http://www.learnerassociates.net/proposal/ Reasons Proposals Fail http://chronicle.com/article/How-to-Fail-in-Grant- Writing/125620/--let More general resources

62. New and Early Stage Investigators http://grants.nih.gov/grants/new_investigators/ New and Early Stage Investigator Resources

63. http://public.csr.nih.gov/Pages/default.aspx http://grants.nih.gov/grants/oer.htmhttp://grants.nih.gov/grants/oer.htm (forms, grant search, etc.) NIH Websites

64. SSRI Listserv New subscribers can join the SSRI listserv by sending mail to: L-SSRI-subscribe-request@lists.psu.edu